Hemab Therapeutics Holdings, Inc. (COAG) Stock

Hemab Therapeutics Holdings, Inc. (COAG) is a Healthcare stock trading at $48.12 (as of 2026-08-20), with a market capitalization of $2.25B. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Valuation — source: SEC EDGAR (first-party)
Price$48.12
Market Cap$2.25B
FCF Yield-5.2%
Valuation vs Sector & Industry
Sector P/E (Healthcare)21.6
Industry P/E (Pharmaceutical Products)17.2
Company
SectorHealthcare
IndustryPharmaceutical Products

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Iovance Biotherapeutics, Inc. (IOVA)
  • Relay Therapeutics, Inc. (RLAY)
  • Tarsus Pharmaceuticals, Inc. (TARS)
  • Beam Therapeutics Inc. (BEAM)
  • Kodiak Sciences Inc. (KOD)
  • BioCryst Pharmaceuticals, Inc. (BCRX)
  • ADMA Biologics, Inc. (ADMA)
  • Vericel Corporation (VCEL)
COAG earnings history · COAG institutional & insider holders · COAG KPIs & operating metrics · COAG financials · COAG investor presentations & press releases · COAG SEC filings · COAG peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-20.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.